Skip to main content
Clinical Trials/NL-OMON35660
NL-OMON35660
Completed
Not Applicable

The occurrence of cerebral embolism (CE) in catheter ablation of atrial fibrillation (AF) using three different ablation catheters - Cerebral embolism in AF-ablation (CE-AF).

eids Universitair Medisch Centrum0 sites270 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
palpitations
Sponsor
eids Universitair Medisch Centrum
Enrollment
270
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Any patient scheduled for a first ablation of paroxysmal atrial fibrillation

Exclusion Criteria

  • Any patient unwilling or unable to give informed consent
  • Minors and incapacitated adults
  • Any patient with contra\-indications to DW\-MRI of the brain or DE\-MRI of the left atrium
  • Any patient unable to undergo neuropsychological testing due to mental retardation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Incidence of silent cerebral thromboembolism during catheter ablation of atrial fibrillatioI48.10
DRKS00000782Cardoangiologisches Centrum Bethanien99
Completed
Not Applicable
Evaluation of cerebral microembolism related to left atrial ablation of paroxysmal atrial fibrillatioI48.10I63.4Cerebral infarction due to embolism of cerebral arteries
DRKS00003465niversitätsklinikum Regensburg65
Recruiting
Not Applicable
Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: retrospective studyatrial fibrillation
JPRN-UMIN000020635ational Cerebral and Cardiovascular Center Department of Cardiovascular Medicine Division of Arrhythmia and Electrophysiology400
Completed
Not Applicable
Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: prospective studyAtrial fibrillation
JPRN-UMIN000020636ational Cerebral and Cardiovascular Center Department of Cardiovascular Medicine Division of Arrhythmia and Electrophysiology400
Completed
Not Applicable
Cerebral Protection of Acute Embolic Burden During Transcatheter Aortic Valve Implantation * A Randomized Diffusion-Weighted MRI Study (CP-11134)severe headachedizzinessdifficulty in walkingloss of balance and coordinationblurred or double vision.Stroke: inability to move one or more limbs on one side of the bodyinability to understand or formulate speechinability to see one side of the visual fieldsudden10046973
NL-OMON42354Claret Medical, Inc.24